
Sign up to save your podcasts
Or


As Canada marks six years of cannabis legalization, we explore the shifting landscape of cannabis use among older adults, the fastest-growing group of consumers.
In this episode, Western professor Jibran Khokhar, PhD, delves into the latest research on edibles, oils, THC, CBD, and even psychedelics, examining their potential effects on the aging body and brain. Are older adults use cannabis for medicinal purposes or it is just for recreation? Are the effects of cannabis real or could it simply be a placebo effect? Tune in to find out.
Tune in to explore the link between gait and cognition, and learn how the right dose of physical exercise and cognitive training can delay the onset of dementia.
In this episode of The Catalysts, renowned Western University geriatrician Dr. Manuel Montero-Odasso, discusses the connection between falls, frailty and mobility issues, and cognitive decline in older individuals. Dr. Montero-Odasso shares how his research using motor biomarkers, dual-task gait testing and innovative interventions, such as the SYNERGIC Trials, is proving effective in delaying dementia in individuals with mild cognitive impairment. Tune in to learn about the vital role of mobility in aging and the promising strategies to maintain cognitive and physical health as we grow older.
Learn how the TRIDENT Platform is Revolutionizing Drug Discovery for Neurodegenerative Diseases Like Alzheimer's and Parkinson's
In this debut episode of The Catalysts, we explore the cutting-edge, open-source TRIDENT research platform, that's revolutionizing and de-risking the drug discovery pipeline for neurodegenerative diseases by focusing on "failing faster" — a strategy designed to save time and money, and ultimately lives. Join Schulich School of Medicine & Dentistry and Robarts Research Institute scientists Dr. Lisa Saksida and Dr. Ravi Menon as they discuss how this innovative approach led by an interdisciplinary team of scientists at Western University is key to finding the most promising drugs and therapies for age-related diseases like Alzheimer's, Parkinson's, and dementia while sparing patients from false hope.
Here is your sneak peek to the Catalysts miniseries on the science of aging, featuring fascinating talks with top scientists and clinicians transforming the field, plus an exclusive conversation with the 2024 Taylor Prize laureate.
This miniseries is in association with the J. Allyn Taylor International Prize in Medicine — one of Canada's most prestigious medical research awards — awardded by the Schulich School of Medicine & Dentistry and Robarts Research Institute, Western University.
From the publisher's feed